Silverado Resort – Napa, California
April 30 – May 2, 2020
Dr. Laura Niklason, Yale University and Dr. Frederick Schoen, Harvard University
Martin Birchall, MD (University College of London)
Karen Christman, PhD (University of California San Diego)
Jennifer Elisseeff, PhD (Johns Hopkins University)
Adam Feinberg, PhD (Carnegie Mellon University)
Cyrus Ghajar, PhD (Fred Hutchinson Cancer Research Center)
Kirk Hansen, PhD (University of Colorado)
George Hussey, PhD (University of Pittsburgh)
Alberto Mantovani, MD (Humanitas University)
Robert Mecham, PhD (Washington University)
Celia Witten, MD, PhD (Food and Drug Administration)
Now Accepting Abstract Submissions!
Abstracts will be considered for all topics related to the use of biologic scaffolds for tissue engineering/regenerative medicine applications including: fundamental concepts of cell-scaffold interactions, tissue source and processing/manufacturing methods, whole organ engineering, pre-clinical studies of tissue and organ repair/reconstruction, factors that influence the host remodeling response, and results/outcomes of human clinical studies with biologic surgical meshes. Abstracts will be considered for podium presentation and poster session display. It is anticipated that approximately 50% of the accepted abstracts for podium presentation will relate to the human clinical experience with biologic surgical meshes. The other 50% will relate to basic science and mechanistic concepts of biologic scaffold remodeling including immunomodulation, stem/progenitor cell interactions with biologic materials, mechanobiology, and bioactive components of extracellular matrix, among others.
Abstracts will be accepted from August 15, 2019 to December 1, 2019. Notification of abstract decision will be sent by no later than January 15, 2020.
Abstracts should be no longer than (approximately) 750 words or one page of text, including figures (if any).
Author listing should include full first and last names and affiliations.
The abstract should clearly describe the nature of the research and be presented in such language as to be understood by both scientists and clinicians. The abstract should clearly identify the objectives of the research, the methodology employed, the results, and conclusions.
Please contact Rachel Thomas at firstname.lastname@example.org or (412) 624-5252 with any questions.